Skip to main content Skip to navigation

Gibson Group: Kathryn Murray


Kat was born in Reading in 1991 and moved to Malvern shortly after. From 2009-2013 Kat studied for an MChem in Chemistry for Drug Discovery at the University of Bath with an industrial placement year, spent at Abbott Diabetes Care in Witney. Her masters project, supervised by Dr Toby Jenkins, focussed on the development of carboxyfluorescein- encapsulated giant unilamellar vesicles (GUVs) for the detection of bacteria in burn wounds.

Following graduation with first class honours, Kat moved to Yorkshire to work for Systagenix, a wound care company. After a year in industry, Kat returned to academia to start a PhD at the University of Sheffield on the CDT for polymers, soft matter and colloids with Dr Sebastian Spain and Professor Sheila MacNeil.

Kat’s PhD project focussed on developing a prodrug to treat burn scar contracture, testing small molecule prodrugs in a 3D tissue engineered model of human skin. During her PhD, Kat spent 6 months working for Redx Pharma, a small drug discovery company based at Alderley Park, Cheshire.


Murray. K, Bullock. A, MacNeil. S, Spain. S. G. (2018) Development of a Topical Prodrug for Lysyl Oxidase Inhibition, In preparation.

Bleasdale. B, Finnegan. S, Murray. K, Kelly. S, Percival. S. L., (2015). The Use of Silicone Adhesives for Scar Reduction. Advances in Wound Care, 4 (7), 422-430. DOI:10.1089/wound.2015.0625